Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
10/2009
10/15/2009CA2720530A1 Sulfonamides
10/14/2009EP2108647A1 Bromination process of 3-alkylthiophenes
10/14/2009EP1856090B1 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548990C Processes for preparing benzo[b]thiophene derivatives
10/14/2009CN100548982C Heteropolycyclic compound and dye
10/14/2009CN100548473C Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601849 Phenyl-tetracyanobutadienyl thiophene-stilbene-based NLO chromophore; films; heat resistance
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009US7601503 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009US20090253919 Chiral thiourea compounds and process for enantioselective reduction of ketones
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253766 Thiophene derivatives as factor xia inhibitors
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009CA2720038A1 Novel donor-acceptor fluorene scaffolds: a process and uses thereof
10/07/2009EP2107057A1 Process for the preparation of pure duloxetine hydrochloride
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009EP1709027B1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/07/2009CN101553461A 4-substituted phenoxyphenylacetic acid derivatives
10/07/2009CN101550047A Method of de-alkyl amine
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598667 which act as hole transporting and luminescent host materials for both fluorescent and phosphorescent emission
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598422 Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598401 Poly(phenoxyalkanoic acid esters) of polyols in which the phenyl rings are substituted with sulfonium salts of thioxanthenes or thioxanthones; for use in surface coating applications, such as printing inks and varnishes
10/06/2009US7598284 Indazole compounds as B3 adrenoceptor agonist
10/01/2009WO2009120783A1 High affinity inhibitors of hepatitis c virus ns3/4a protease
10/01/2009WO2009119428A1 Dye for dye-sensitized solar cell and dye-sensitized solar cell
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009117829A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009US20090247771 Process for obtaining enantiomers of duloxetine precursors
10/01/2009US20090247596 Thiophenecarboxamide derivatives as ep4 receptor ligands
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090246902 Thiophene derivative and organic electroluminescent element
10/01/2009CA2756800A1 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
09/2009
09/30/2009EP2105442A1 Method for producing c-glycoside derivative and synthetic intermediate thereof
09/30/2009CN101547913A Photoactive compounds
09/30/2009CN101544629A Method for separating enantiomers of rotigotine and trihexyphenidyl
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009CA2379026C Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
09/29/2009CA2328280C Thienopyrimidines
09/29/2009CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas
09/29/2009CA2311922C Thienopyrimidines
09/24/2009WO2009117378A2 Therapeutic amides
09/24/2009WO2009115413A2 Substituted oligo- or polythiophenes
09/24/2009WO2009068520A3 Polymorphic form of rotigotine
09/24/2009WO2009035949A3 Soluble epoxide hydrolase inhibitors
09/24/2009US20090240062 Compound derived from cyclopentadienone, preparation method thereof and el element using the same
09/24/2009US20090240058 Activator for Peroxisome Proliferator-Activating Receptor Delta
09/24/2009US20090239930 Therapeutic compounds
09/24/2009US20090239858 Therapeutic amides
09/24/2009US20090239829 Thioaryl substituted inhibitors of zinc proteases and their use
09/24/2009CA2718713A1 Therapeutic compounds
09/24/2009CA2716929A1 Substituted oligo- or polythiophenes
09/23/2009EP1590322B1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
09/23/2009EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/23/2009CN101541779A IKK-beta serine-threonine protein kinase inhibitors
09/23/2009CN101541778A Thiophenecarboxamide derivatives as EP4 receptor ligands
09/23/2009CN101538262A Bryoanthrathiophenic substance and synthetic method thereof
09/22/2009US7592478 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
09/22/2009US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs)
09/22/2009US7592467 Inhibitors of prolyl endopeptidase
09/22/2009US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists
09/22/2009US7592366 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted cyclopentane compounds; Isopropyl 5-(3-((1R,2R,3R,5R)-5-chloro-2-(3-chloro-5-(hydroxymethyl)phenethyl)-3-hydroxycyclopentyl)propyl)thiophene-2-carboxylate for example
09/22/2009CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
09/17/2009WO2009114467A1 Therapeutic cyclopentane derivatives
09/17/2009WO2009113320A1 Mmp inhibitor
09/17/2009WO2009112845A1 Amido-thiophene compounds and their use
09/17/2009WO2009067493A3 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
09/17/2009US20090234138 Acyloxyalkyl carbamate prodrugs, methods
09/17/2009US20090234084 Metallocene Compounds
09/17/2009US20090233921 Therapeutic cyclopentane derivatives
09/17/2009US20090231678 Electro-optic chromophore having an edot structure, and related methods and apparatuses
09/17/2009US20090230855 Novel organic compound and organic light emitting device comprising the same
09/17/2009CA2716679A1 Amido-thiophene compounds and their use
09/16/2009EP2100877A1 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
09/16/2009EP2100876A2 New compounds for the inhibition of rotamases and use thereof
09/16/2009EP2100875A1 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
09/16/2009EP2100605A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
09/16/2009EP2099741A2 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
09/16/2009EP1478364B1 Selective antibacterial agents
09/16/2009EP1437338B1 Luminous compounds and labeling reagents using the same
09/16/2009EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease
09/16/2009CN101535290A Method for producing 2-alkyl-3-aminothiophene derivative
09/16/2009CN101535289A Novel phenylacetic acid derivative
09/16/2009CN101535288A A novel process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 329